what is going on with tirzepatide Compounded 5MG Tirzepatide (Zepbound) for weight loss

In the landmark 72-week SURMOUNT-1 trial, participants on the 15 mg dose recorded a mean body-weight reduction of 20.9%, versus 3.1% on placebo[1]. 57% of that group lost a fifth or more of their body weight, and 91% lost at least 5%[1]

Gastrointestinal safety of semaglutide and tirzepatide vs placebo in obese individuals without diabetes: a systematic review and meta-analysis

What qualifies you for tirzepatide

In a study that compared Ozempic vs Mounjaro, Mounjaro (in doses of 5 mg, 10 mg, and 15 mg) worked more effectively than the 1 mg dose of Ozempic

Retatrutide itself has only been studied as a standalone agent in controlled clinical trial settings